Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 3
Submit an article Journal homepage
597
Views
13
CrossRef citations to date
0
Altmetric
Articles

Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population

M. Valentia Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9140-9263
ORCID Icon,
G. Paviaa Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy
,
L. Gargiuloa Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy
,
P. Facherisa Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy
,
F. Sannaa Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy
,
R. G. Borronia Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy
,
A. Costanzoa Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy;b Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy
&
A. Narcisia Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy
 show all
Pages 1638-1642 | Received 28 Jan 2021, Accepted 02 Feb 2021, Published online: 15 Feb 2021

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Flavia Sunzini, Arianna D’Antonio, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Elisabetta Greco, Alberto Bergamini & Maria Sole Chimenti. (2022) What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?. Expert Opinion on Biological Therapy 22:12, pages 1545-1559.
Read now

Articles from other publishers (12)

M. Magnano, R. Balestri, P. Gisondi, F. Bardazzi, V. Di Lernia, T. Ioris, C. R. Girardelli & G. Rech. (2023) Biologics in psoriatic patients with malignancies: Where are we now? An Italian multicentric study. Journal of the European Academy of Dermatology and Venereology.
Crossref
Paula Finnegan, Kashif Ahmad, Muriel Sadlier & Maeve Lynch. (2023) A retrospective review of the management of patients following a malignancy diagnosis on biologic therapies for the treatment of dermatological disorders. JAAD Case Reports 39, pages 81-87.
Crossref
Elena Carmona-Rocha & Lluís Puig. (2023) Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy.
Crossref
G. Fiorillo, L. Ibba, L. Gargiulo, C. A. Vignoli, A. Alfano, A. Cortese, F. Toso, D. Orsini, P. Iacovelli, P. Frascione, A. Narcisi, A. Costanzo & M. Valenti. (2023) Effectiveness and safety of anti‐IL ‐23 and anti‐IL ‐17 biological therapies for psoriasis in elderly patients: Real‐world experience from two Italian hospitals . Journal of the European Academy of Dermatology and Venereology.
Crossref
Kim A. Papp, Barbara Melosky, Sandeep Sehdev, Sebastien J. Hotte, Jennifer R. Beecker, Mark G. Kirchhof, Irina Turchin, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Jo Lambert, Charles W. Lynde, Vimal H. Prajapati & Ronald B. Vender. (2023) Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and Therapy 13:4, pages 867-889.
Crossref
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, Luciano Ibba, Fabrizio Amoruso, Giuseppe Argenziano, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Giampiero Girolomoni, Claudio Guarneri, Francesco Loconsole, Francesca Sampogna, Massimo Travaglini, Piergiorgio Malagoli & Antonio Costanzo. (2022) Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— IL PSO ( Italian landscape psoriasis ) . Journal of the European Academy of Dermatology and Venereology 37:1, pages 93-103.
Crossref
Cristina Pellegrini, Maria Esposito, Ernesto Rossi, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Andrea Conti, Alessio Gambardella, Martina Burlando, Alessandra Narcisi, Annamaria Offidani, Riccardo Balestri, Federico Bardazzi, Francesca Prignano, Cristina Mugheddu, Marco Romanelli, Giovanna Malara, Giovanni Schinzari & Maria Concetta Fargnoli. (2022) Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study. Dermatology and Therapy 12:11, pages 2613-2626.
Crossref
Juan Ortiz Álvarez, Lourdes Rodríguez Fernández-Freire, Juan Carlos Hernández-Rodríguez, Román Barabash-Neila, Antonio José Durán-Romero, Mercedes Morillo-Andújar & Julián Conejo-Mir Sánchez. (2022) Efficacy and safety of biological therapy in patients with psoriasis and recent neoplasia: experience in real single-center clinical practice. Archives of Dermatological Research 315:4, pages 1045-1048.
Crossref
Nicoletta Bernardini, Nevena Skroza, Anna Marchesiello, Alessandra Mambrin, Ilaria Proietti, Ersilia Tolino, Patrizia Maddalena, Federica Marraffa, Giovanni Rossi, Salvatore Volpe & Concetta Potenza. (2022) Psoriatic patients with a history of cancer: A real‐life experience with Apremilast treatment for 104 weeks. Dermatologic Therapy 35:10.
Crossref
Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Carlo Alberto Vignoli, Francesco Piscazzi, Mario Valenti, Federica Sanna, Chiara Perugini, Jessica Avagliano, Antonio Costanzo & Alessandra Narcisi. (2022) Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study. Dermatology and Therapy 12:10, pages 2309-2324.
Crossref
Mario Valenti, Alessandra Narcisi, Giulia Pavia, Luigi Gargiulo & Antonio Costanzo. (2022) What Can IBD Specialists Learn from IL-23 Trials in Dermatology?. Journal of Crohn's and Colitis 16:Supplement_2, pages ii20-ii29.
Crossref
Luigi Gargiulo, Giulia Pavia, Mario Valenti, Ana Lleo de Nalda, Chiara Perugini, Antonio Costanzo & Alessandra Narcisi. (2022) Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study. Dermatology and Therapy 12:5, pages 1263-1270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.